Current safety practices relating to I-131 administration for diseases of the thyroid: A survey of physicians and allied practitioners

Thyroid

Volumn 21, Issue 2, 2011, Pages 151-160

  Greenlee, Carol ^a   Burmeister, Lynn A ^b   Butler, Robert S ^c   Edinboro, Charlotte H ^d   Morrison, Shannon McIntyre ^c   Milas, Mira ^c  

^a Western Slope Endocrinology   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d EXPONENT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ARTICLE; BREAST FEEDING; CANADA; CANCER RISK; FEMALE; FOOD PROCESSING; GENDER; GEOGRAPHY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LAUNDRY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEXICO; OUTPATIENT; PARENTHOOD; PATIENT SELECTION; PERSONAL HYGIENE; PHYSICIAN; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION SAFETY; RADIOLOGIST; REPRODUCTION; SEROLOGY; SEXUAL BEHAVIOR; SURGEON; THYROID DISEASE; UNITED STATES; URINALYSIS;

ALLIED HEALTH PERSONNEL; CANADA; DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, RADIATION; GOITER; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MEXICO; PHYSICIAN'S PRACTICE PATTERNS; SAFETY MANAGEMENT; THYROID DISEASES; THYROID NEOPLASMS; UNITED STATES;

EID: 79953245750     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0090     Document Type: Article

References (13)

1. National Council on Radiation Protection and Measurements 2006 Management of Radionuclide Therapy Patients. NCRP Report No. 155. National Council on Radiation Protection and Measurements, Bethesda, MD.
2. Sparks RB, Siegel JA, Wahl RL 1998 The need for better methods to determine release criteria for patients administered radioactive material. Health Phys 75:385-388. (Pubitemid 28453175)
3. Grigsby PW, Siegel BA, Baker S, Eichling JO 2000 Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma. JAMA 283:2272-2274.
4. Barrington SF, O'Doherty MJ, Kettle AG, Thomson WH, Mountford PJ, Burrell DN, Farrell RJ, Batchelor S, Seed P, Harding LK 1999 Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med 26:686-692. (Pubitemid 29338655)
5. Carey JL, Kumpuris TM, Wrobel MC 1995 Release of patients containing therapeutic dosages of iodine-131 from hospitals. J Nucl Med Technol 23:144-149.
6. Ibis E, Wilson CR, Collier BD, Akansel G, Isitman AT, Yoss RG 1992 Iodine-131 contamination from thyroid cancer patients. J Nucl Med 33:2110-2115.
7. Barrington SF, Anderson P, Kettle AG, Gadd R, Thomson WH, Batchelor S, Mountford PJ, Harding LK, O'Doherty MJ 2008 Measurement of the internal dose to families of out-patients treated with (131)I for hyperthyroidism. Eur J Nucl Med Mol Imaging 35:2097-2104.
8. Thomson WH, Harding LK 1995 Radiation protection issues associated with nuclear medicine out-patients. Nucl Med Commun 16:879-892.
9. Vaidya B, Williams GR, Abraham P, Pearce SH 2008 Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clin Endocrinol 68:814-820. (Pubitemid 351533433)
10. Monsieurs M, Thierens H, Dierckx RA, Casier K, De Baere E, De Ridder L, De Saedeleer C, De Winter H, Lippens M, van Imschoot S, Wulfrank D, Simons M 1998 Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium). Eur J Nucl Med 25:1368-1376. (Pubitemid 28464110)
11. Woodings S 2004 Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromocytoma patients. Australas Phys Eng Sci Med 27:118-128. (Pubitemid 39517320)
12. Dietlein M, Troche CJ, Moka D, Bausch V, Lauterbacj KW, Schicha H 1998 Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy. Nuklearmedizin 37:33-40.
13. American Hotel and Lodging Association. Available at www.ahla.com/. Accessed October 26, 2010.